Temple Therapeutics
PrivateLast Round
Early Funding
Dec 26, 2023
Total Funding Raised
$4.35M
Company Overview
Temple Therapeutics is a biotechnology company that develops novel therapies and diagnostics for women's health conditions such as endometriosis, ovarian cancer, and tissue fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Temple Therapeutics Comparables
Compare Temple Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EndoCyclic Therapeutics | 85% | |
| FimmCyte | 72% | |
| Hope Medicine | 68% |
Temple Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 26, 2023 | ||||
| VC Round | May 3, 2022 | ||||
| Grant | Aug 27, 2019 | ||||
| Series B | Mar 13, 2018 |
Temple Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eurostars SME programme | Grant |
| Dominick & Dickerman LLC | Series B |
| TerraNova Capital Partners | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2022
$350K raised in a VC Round.
- Aug 27, 2019
$3M grant from Eurostars SME programme and other institutions.
Temple Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Temple Therapeutics's valuation, stock price, and market status.
Is Temple Therapeutics a public or private company?
Temple Therapeutics is a private company.
What is the current stock price of Temple Therapeutics?
Temple Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Temple Therapeutics worth (valuation)?
Valuation information for Temple Therapeutics is not publicly available.
Can I buy Temple Therapeutics stock?
Temple Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Temple Therapeutics's last funding round?
Temple Therapeutics's most recent funding round was Early Funding on December 26, 2023.
Who are the main investors in Temple Therapeutics?
Key investors in Temple Therapeutics include Eurostars SME programme, Dominick & Dickerman LLC.
Will Temple Therapeutics IPO soon?
No public IPO plans have been announced for Temple Therapeutics.
How can I track Temple Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Temple Therapeutics's secondary market activity and sign up for updates.